Skip to content
Palanor is in early release, with our founding customers.Become a founding customer →
The Real Rate Index45.30.00Palanor: Inflation Pulse50.7+0.06Palanor: Geopolitical Stress59.7-0.25Palanor: Liquidity58.8+0.87Palanor: Capital Tightness46.4-1.11Palanor: Industrial Pulse70.10.00Palanor: AI Margin Compression52.8-0.63Palanor: Consumer Confidence47.1-1.44Palanor: US Dollar Strength46.5+0.01Palanor: Labor Heat63.20.00Palanor: Recession Vocabulary28.7+0.64Palanor: Uncertainty Index53.2-0.24Palanor: US Jobs Health40.30.00Palanor: Energy Transition37.7+0.74Palanor: Reshoring Sentiment22.7-0.15Palanor: AI Substitution28.6+0.24The Social Fabric Index45.70.00Palanor: Geopolitical Anxiety19.8+0.43Palanor: Quit Pressure34.7-2.85The Mania Index88.00.00The Palanor Index57.5+0.37Cost Disease Spread33.20.00Palanor: US vs China49.4-0.05Rise of Socialism Index40.6-0.18The Bubble Memory98.5-0.00Palanor: Steward Confidence51.0+0.19The Long Watch90.30.00The Reshoring Index55.20.00The Capital Return Index80.2-0.77The Discourse Index74.3+1.91The Hesitation Index33.4+2.64Palanor AI Inference Cost Index71.2-0.03The AI Capex Race Index76.1-2.39The Boardroom Index81.7-0.84The Layoff Cycle Index35.6+2.75Capital Deployment Posture Index61.7-0.67The Consumer Health Index41.8+0.07Labor Hours Composite44.40.00The Dollar Erosion Index65.5-1.13Palanor: Risk Appetite35.4-0.76
PalanorPalanor

Latest reading, ranked

New Industry Clinical Trials by Therapeutic Area

Company-led trials newly registered on ClinicalTrials.gov, average per month in the latest calendar year (year to date)

Cancer leads at 97
YTD1y2y5y10y20yAll
Current·Data to 2026

Plays the chart through its history. Pauses are where a new leader takes first place.

ClinicalTrials.gov (U.S. National Library of Medicine). Trials counted in the month ClinicalTrials.gov first posted them. The U.S. government does not review or approve the safety and science of all studies listed. A trial can fall in more than one area.

Where pharma and biotech are putting new trials. Cancer has led by a wide margin for years; the other areas show where research money is moving.

What this chart reads·8 series

Show all

Sources·8 sources

Show all

New Industry Trials Registered: Cancer (Monthly). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

New Industry Trials Registered: Heart and Blood Vessel Disease (Monthly). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

New Industry Trials Registered: Nervous System Disease (Monthly). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

New Industry Trials Registered: Mental Health (Monthly). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

New Industry Trials Registered: Infectious Disease (Monthly). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

New Industry Trials Registered: Immune System Disease (Monthly). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

New Industry Trials Registered: Metabolic Disease (Monthly). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

New Industry Trials Registered: Respiratory Disease (Monthly). Source: ClinicalTrials.gov (U.S. National Library of Medicine), API v2, refreshed weekly. Palanor counts and classifies the records as described above; it does not change them. ClinicalTrials.gov disclaimer: the U.S. government does not review or approve the safety and science of all studies listed; sponsors and investigators are responsible for their listings.

Charts are drawn from Palanor's signal library and recomputed from source data on every view. Transformations (changes, indexing, year-on-year rates) are Palanor's.

Related charts

HealthForecastMoving

Drug Stocks Against the Market

Twenty large U.S.-listed drugmakers (by market value) and the S&P 500, price indexed to the start of the window

199.8Data yesterday
HealthForecast

U.S. Uninsured Rate

Share of people in the United States with no health insurance, annual, %

8.2%Data to Dec 2024
HealthForecast

FDA Novel Drug Approvals

New drugs approved by the FDA’s drug center, trailing 12 months

59Data 52 days ago
HealthForecast

U.S. Drug Overdose Deaths

Drug overdose deaths in the U.S., 12 months ending each month

66,478Data to May 2026
Health· StudioForecast

FDA Novel Drug Approvals, Trailing 12 Months

New molecular entities and new therapeutic biologics approved by FDA's Center for Drug Evaluation and Research.

59.0Data 52 days ago
HealthForecast

Donor Aid for Health

Bilateral aid disbursements from DAC member countries by sector, US$ billions, current prices, yearly

$7.3B1 viewsData to Dec 2024

Cookies

We only use essential cookies to keep you signed in and remember your theme. No analytics, no tracking, no ads. See the Privacy Policy for the full read.